RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 151 filers reported holding RA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 16.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,503,000 | +2.3% | 31,300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,469,000 | +93.5% | 31,300 | -2.5% | 0.00% | +100.0% |
| Q3 2019 | $759,000 | -21.3% | 32,100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $965,000 | +167.3% | 32,100 | +99.4% | 0.00% | – |
| Q1 2019 | $361,000 | +23.2% | 16,100 | 0.0% | 0.00% | – |
| Q4 2018 | $293,000 | +0.7% | 16,100 | 0.0% | 0.00% | – |
| Q3 2018 | $291,000 | +81.9% | 16,100 | 0.0% | 0.00% | – |
| Q2 2018 | $160,000 | +566.7% | 16,100 | +257.8% | 0.00% | – |
| Q1 2018 | $24,000 | -36.8% | 4,500 | 0.0% | 0.00% | – |
| Q4 2017 | $38,000 | -81.3% | 4,500 | -67.6% | 0.00% | – |
| Q3 2017 | $203,000 | -21.9% | 13,900 | 0.0% | 0.00% | – |
| Q2 2017 | $260,000 | +64.6% | 13,900 | +87.8% | 0.00% | – |
| Q1 2017 | $158,000 | – | 7,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|